dpi | 27 | 30 | 33 | 36 | 39 | 42 | 45 |
---|
Group 1 | 6/0/6b | 4/0/6 | 4/0/6 | 5/2/6 | 6/2/6 | 6/0/6 | 3/0/6 |
Group 2 | 6/0/6 | 5/0/6 | 5/1/6 | 5/4/6 | 4/4/4 | 1/1/1 | 0/0/0 |
Group 3 | 0/0/3 | 0/0/3 | 0/0/3 | 0/0/3 | 0/0/3 | 0/0/3 | 0/0/3 |
Group 4 | 0/0/3 | 0/0/3 | 0/0/3 | 0/0/3 | 0/2/3 | 0/2/3 | 0/0/0 |
- Group 1: PCV2-infected/LPC-vaccinated/CSFV-challenged; group 2: PCV2-infected/CSFV-challenged; group 3: LPC-vaccinated/CSFV-challenged, and group 4: CSFV-challenged.
- aThe pigs were inoculated with 105.3 TCID50 of PCV2 (group 1 and 2), 1 dose of LPC vaccine (group 1 and 3), and 106.8 TCID50 of wild-type CSFV (ALD) (group 1, 2, 3, and 4) at 0, 12, and 27 dpi, respectively. The PCV2 and wild-type CSFV loads in saliva were detected by real-time PCR or reverse transcription real-time PCR, respectively.
- bNumber of PCV2-positive animals/number of wild-type CSFV-positive animals/number of surviving animals.